Clinical Trial

Development of a Novel Algorithm for Real-Time Bedside Assessment of Insulin Resistance in Critically Ill Patients Based on Continuous Glucose Monitoring Data

Completed
View on ClinicalTrials.gov →
Summary
This study aims to develop and validate a novel algorithm for the real-time assessment of insulin resistance in critically ill patients using Continuous Glucose Monitoring (CGM). Current methods for assessing insulin resistance are often invasive or unfeasible in the intensive care setting. By analyzing the dynamic correlation between CGM readings and reference blood glucose fluctuations, the investigators seek to construct a new algorithmic metric. The study will further evaluate the association of this new metric with established insulin resistance indices, organ function, and patient clinical outcomes.
Trial Details
NCT Number NCT07385391
Lead Sponsor Chinese Medical Association
Conditions Critical Illness, Metabolism Disorders, Insulin Resistance
Enrollment 179 participants
Start Date 2023-07-13
Primary Completion 2024-03-13 (estimated)
Study Completion 2025-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-04